These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1016 related articles for article (PubMed ID: 17056190)

  • 1. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
    Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
    Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients.
    Nordsmark M; Eriksen JG; Gebski V; Alsner J; Horsman MR; Overgaard J
    Radiother Oncol; 2007 Jun; 83(3):389-97. PubMed ID: 17499868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
    Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
    Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.
    Le QT; Kong C; Lavori PW; O'byrne K; Erler JT; Huang X; Chen Y; Cao H; Tibshirani R; Denko N; Giaccia AJ; Koong AC
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):167-75. PubMed ID: 17707270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
    Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
    Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
    Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; de Bock GH; Langendijk JA; Kluin PM; Schuuring E; van der Laan BF; van der Wal JE
    Laryngoscope; 2013 Sep; 123(9):2154-60. PubMed ID: 24167820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
    Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
    Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
    Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
    Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.
    Ostheimer C; Bache M; Güttler A; Kotzsch M; Vordermark D
    Strahlenther Onkol; 2014 Mar; 190(3):276-82. PubMed ID: 24322994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous hypoxia markers: case not proven!
    Mayer A; Höckel M; Vaupel P
    Adv Exp Med Biol; 2008; 614():127-36. PubMed ID: 18290322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.
    Shan X; Wang D; Chen J; Xiao X; Jiang Y; Wang Y; Fan Y
    J Comput Assist Tomogr; 2013; 37(1):22-8. PubMed ID: 23321829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients.
    Kaya AO; Gunel N; Benekli M; Akyurek N; Buyukberber S; Tatli H; Coskun U; Yildiz R; Yaman E; Ozturk B
    J BUON; 2012; 17(4):663-8. PubMed ID: 23335522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the hypoxia-inducible factor pathway important in gastric cancer?
    Griffiths EA; Pritchard SA; Welch IM; Price PM; West CM
    Eur J Cancer; 2005 Dec; 41(18):2792-805. PubMed ID: 16290133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-related molecules HIF-1α, CA9, and osteopontin : predictors of survival in patients with high-grade glioma.
    Erpolat OP; Gocun PU; Akmansu M; Ozgun G; Akyol G
    Strahlenther Onkol; 2013 Feb; 189(2):147-54. PubMed ID: 23263636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.
    Kim SJ; Rabbani ZN; Dewhirst MW; Vujaskovic Z; Vollmer RT; Schreiber EG; Oosterwijk E; Kelley MJ
    Lung Cancer; 2005 Sep; 49(3):325-35. PubMed ID: 15935515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.